Status Epilepticus Management and Chronic Seizure Control

First-Line Treatment for Status Epilepticus

The American Academy of Neurology recommends administering IV lorazepam 4 mg at 2 mg/min as first-line treatment for status epilepticus, demonstrating 65% efficacy in terminating seizures 1
For patients without IV access, rectal diazepam is an alternative 2

After adequate benzodiazepine dosing, administer one of the following agents based on patient-specific factors: valproate, fosphenytoin, or levetiracetam 3, 4, 1
Valproate dosing is 20-30 mg/kg IV over 5-20 minutes, with efficacy of 88% seizure control and minimal hypotension risk 1
Fosphenytoin dosing is 20 mg PE/kg IV at a maximum rate of 150 PE/min, with efficacy of 84% seizure control and 12% hypotension risk 1

Midazolam infusion is the first choice for refractory status epilepticus, with a loading dose of 0.15-0.20 mg/kg IV and continuous infusion of 1 mg/kg/min, titrated up to 5 mg/kg/min 1
Propofol is an alternative for intubated patients, with a loading dose of 2 mg/kg bolus and continuous infusion of 3-7 mg/kg/hour, titrated to EEG burst suppression 1

For generalized tonic-clonic seizures, sodium valproate is a first-line treatment option, with lamotrigine and levetiracetam as suitable alternatives 2
For complex partial seizures, carbamazepine, oxcarbazepine, lamotrigine, and levetiracetam are first-line treatment options 2

In patients with end-stage renal disease, valproate dose may need to be increased to 750-1000 mg daily, and levetiracetam may be a superior option due to predictable dosing adjustments for dialysis 5

Never use neuromuscular blockers alone for status epilepticus management, and do not skip to third-line agents until benzodiazepines and a second-line agent have been tried 1
Avoid phenobarbital and phenytoin as first-choice drugs for long-term management due to sedative effects and cognitive/cerebellar dysfunction
Monitor for thrombocytopenia with valproate, and avoid valproate in women of childbearing potential due to teratogenicity
Do not abruptly discontinue antiepileptic drugs due to risk of precipitating status epilepticus
Check HLA-B*1502 in Asian patients before starting carbamazepine due to Stevens-Johnson syndrome risk
Continuous vital sign monitoring is essential during acute treatment, particularly respiratory status and blood pressure 1
Prepare for respiratory support regardless of administration route 1
EEG monitoring should guide titration in refractory status epilepticus to achieve seizure suppression 1